Title | Enzyme-targeted fluorescent imaging probes on a multiple antigenic peptide core. |
Publication Type | Journal Article |
Year of Publication | 2006 |
Authors | Galande AK, Hilderbrand SA, Weissleder R, Tung C-H |
Journal | J Med Chem |
Volume | 49 |
Issue | 15 |
Pagination | 4715-20 |
Date Published | 2006 Jul 27 |
ISSN | 0022-2623 |
Keywords | Cathepsins, Dendrimers, Dipeptides, Fluorescent Dyes, Hydrolysis, Polyethylene Glycols, Solubility, Spectrometry, Fluorescence, Structure-Activity Relationship |
Abstract | Peptide dendrimers have a variety of applications in biology such as the vehicles for drug and gene delivery, molecular inhibitors, protein mimics, and synthetic vaccines. The multiple antigenic peptide (MAP) system is a well-known example of a discrete, dendrimeric scaffold. We explored a novel application of the MAP-based scaffold by designing molecular probes that fluoresce only after enzymatic treatment. The probes, which were synthesized on solid support, incorporate a cathepsin S dipeptide substrate (Leu-Arg), and a poly(ethylene glycol) (PEG) chain in their dendritic arms. The fluorescence emission of the near-infrared fluorochromes attached to the N-termini of the dendritic arms was quenched. Mechanistic studies revealed formation of H-type dye aggregates within the tetravalent MAP system. By varying the length of the PEG chain, three probes were synthesized, CyPEG-1, CyPEG-2, and CyPEG-3 with 4, 8, and 12 ethylene oxide units, respectively. CyPEG-2 showed optimum aqueous solubility and quenching efficiency for imaging applications. Upon proteolytic activation with cathepsin S (EC 3.4.22.27), CyPEG-2 showed greater than 70-fold increase and more than 95% recovery in fluorescence emission. |
DOI | 10.1021/jm051001a |
Alternate Journal | J Med Chem |
PubMed ID | 16854078 |
Grant List | P50-CA86355 / CA / NCI NIH HHS / United States R01 CA99385 / CA / NCI NIH HHS / United States R21 CA114149 / CA / NCI NIH HHS / United States T32-CA79443 / CA / NCI NIH HHS / United States |
Related Institute:
Molecular Imaging Innovations Institute (MI3)